Investigation of maternal blood enriched for fetal cells: Role in screening and diagnosis of fetal trisomies

American Journal of Medical Genetics

Volumn 85, Issue 1, 1999, Pages 66-75

  Al Mufti, Raghad ^a   Hambley, Henry ^a   Farzaneh, Farzin ^a   Nicolaides, Kypros H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Assessment of risk; Fetal cells in maternal blood; Fetal trisomy; Fluorescent in situ hybridization; Magnetic cell sorting; Nuchal translucency thickness; Prenatal diagnosis

Indexed keywords

ARTICLE; CELL SELECTION; FETUS; FETUS CELL; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; KARYOTYPE; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL BLOOD; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; TRISOMY;

ADOLESCENT; ADULT; FEMALE; FETOMATERNAL TRANSFUSION; HUMANS; IMMUNOMAGNETIC SEPARATION; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MIDDLE AGED; PREGNANCY; PRENATAL DIAGNOSIS; TRISOMY; X CHROMOSOME; Y CHROMOSOME;

EID: 0033516681     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990702)85:1<66::AID-AJMG11>3.0.CO;2-2     Document Type: Article

References (19)

1. Bianchi DW, Flint AF, Pizzimenti MF, Knoll JHM, Latt SA. 1990. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci USA 87:3279-3283.
2. Bianchi DW, Mahr A, Zickwolf GK, Houseal TW, Flint AF, Klinger KW. 1992. Detection of fetal cells with 47,XY, + 21 karyotype in maternal peripheral blood. Hum Genet 90:368-370.
3. Bryndorf T, Christensen B, Vad M, Parner J, Brocks V, Philip J. 1997. Prenatal detection of chromosome aneuploidies by fluorescence in situ hybridization: experience with 2,000 uncultured amniotic fluid samples in a prospective preclinical trial. Prenat Diagn 17:333-341.
4. Ganshirt-Ahlert D, Burschyk M, Garritsen HSP, Helmer L, Miny P, Horst J, Schneider HP, Holzgreve W. 1992. Magnetic cell sorting and the transferrin receptor as potential means of prenatal diagnosis from maternal blood. Am J Obstet Gynecol 166:1350-1355.
5. Ganshirt-Ahlert D, Borjesson-Stoll R, Burschyk M, et al. 1993. Detection of fetal trisomies 21 and 18 from maternal blood using triple gradient and magnetic cell sorting. Am J Reprod Immunol 30:194-201.
6. Hamada H, Arinami T, Kubo T, Hamaguchi H, Iwasaki H. 1993. Fetal nucleated cells in maternal peripheral blood: frequency and relationship to gestational age. Hum Genet 91:427-432.
7. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. 1992. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 304:867-869.
8. Price JO, Elis S, Wachtel S, Klinger K, Dockter M, Tharapel A, Shulman LP, Phillips OP, Meyers CM, Shook D, et al. 1991. Prenatal diagnosis with fetal cells isolated from maternal blood by multiparameter flow cytometry. Am J Obstet Gynecol 165:1731-1737.
9. Sherod C, Sebire NJ, Soares W, Snijders RJM, Nicolaides KH. 1997. Prenatal diagnosis of trisomy 18 at the 10-14 week ultrasound scan. Ultrasound Obstet Gynaecol 10:387-390.
10. Simpson JL, Elias S. 1994. Isolating fetal cells in maternal circulation for prenatal diagnosis. Prenat Diagn 14:1229-1242.
11. Simpson JL, Lewis DE, Bischoff FZ, Elias S. 1995. Isolating fetal nucleated red blood cells from maternal blood: the Baylor experience - 1995. Prenat Diagn 15:907-912.
12. Snijders RJM, Sebire NJ, Nicolaides KH. 1995. Maternal age and gestational age specific risk for chromosomal defects. Fetal Diagn Ther 10:356-367.
13. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. 1998. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 352:343-346.
14. Snijders RJM, Sebire NJ, Nayar R, Sooka A, Nicolaides KH. 1999. Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation. Am J Med Genet (in press).
15. Spencer K, Souter V, Tul N, Snijders RJM, Nicolaides KH. 1999. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency maternal serum free β-hCG and PAPP-A. Ultrasound Obstet Gynaecol (in press).
16. Taipale P, Hiilesmaa V, Salonen R, Ylostalo P. 1997. Increased nuchal translucency as a marker for fetal chromosomal defects. N Engl J Med 337:1654-1658.
17. Wachtel S, Elias S, Price J, Wachtel G, Phillips O, Shulman L, Meyers C, Simpson JL, Dockter M. 1991. Fetal cells in the maternal circulation: isolation by multiparameter flow cytometry and confirmation by polymerase chain reaction. Hum Reprod 6:1466-1469.
18. Walknowska J, Conte FA, Grumback MM. 1969. Practical and theoretical implications of fetal/maternal lymphocyte transfer. Lancet 1:1119-1122.
19. Ward BE, Gersen L, Carelli MP, McGuire NM, Dackowski WR, Weinstein M, , Sandlin C, Warren R, Klinger KW. 1993. Rapid prenatal diagnosis of chromosomal aneuploidies by fluorescence in situ hybridization: clinical experience with 4,500 specimens. Am J Hum Genet 52:854-865.